Olopatadine Nasal Spray 0.6% is Superior to Vehicle and Non-Inferior to Azelastine Nasal Spray 0.1% When Dosed Twice-Daily for the Treatment of Seasonal Allergic Rhinitis

Methods This was a placebo (vehicle)- and active-controlled, double-masked, randomized, parallel group comparison of OLO versus vehicle and AZE in patients 12 years of age and older with a history of seasonal allergic rhinitis.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S49-S49
Main Authors: Mohar, D, Ratner, P, Shah, S, Drake, M, Crenshaw, K, Wall, G
Format: Article
Language:English
Subjects:
Allergies
Allergy and Immunology
Nose
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods This was a placebo (vehicle)- and active-controlled, double-masked, randomized, parallel group comparison of OLO versus vehicle and AZE in patients 12 years of age and older with a history of seasonal allergic rhinitis.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.200